Transaction Details

Footnotes

1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. | Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2025. | Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2025. The remaining Stock Options vest and become exercisable on March 14, 2026. | Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2025. The remaining Stock Options vest in two equal annual installments beginning on March 20, 2026 | Represents the exercise of time-based Stock Options awarded on March 18, 2024. The subject Stock Options vested and were exercisable as of March 18, 2025. The remaining Stock Options vest in three equal annual installments beginning on March 18, 2026. | Represents the grant of performance-based Stock Options (at 200% target) upon the achievement of an adjusted diluted EPS performance metric for the performance period ended December 31, 2021. One-third of the performance-based Stock Options, being 1,280 Stock Options, vested on March 15, 2023., March 15, 2024 and March15, 2025. | Represents the grant and full vesting of performance-based Stock Options (at 96% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Earnings Per Share (EPS) Growth goals for the three-year performance period ended December 31, 2024. | Represents the grant and full vesting of performance-based Stock Options (at 25% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Total Shareholder Return (TSR) goals for the three-year performance period ended December 31, 2024.